Adverum Biotechnologies Inc (ADVM)
5.75
-0.42
(-6.81%)
USD |
NASDAQ |
Nov 21, 16:00
5.77
+0.02
(+0.35%)
After-Hours: 20:00
Adverum Biotechnologies Price to Book Value: 0.83 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 0.83 |
| November 20, 2024 | 0.8906 |
| November 19, 2024 | 0.9022 |
| November 18, 2024 | 0.9888 |
| November 15, 2024 | 0.9902 |
| November 14, 2024 | 1.046 |
| November 13, 2024 | 1.091 |
| November 12, 2024 | 1.139 |
| November 11, 2024 | 1.120 |
| November 08, 2024 | 1.155 |
| November 07, 2024 | 1.140 |
| November 06, 2024 | 1.146 |
| November 05, 2024 | 1.114 |
| November 04, 2024 | 1.088 |
| November 01, 2024 | 1.070 |
| October 31, 2024 | 1.053 |
| October 30, 2024 | 1.137 |
| October 29, 2024 | 1.12 |
| October 28, 2024 | 1.143 |
| October 25, 2024 | 1.152 |
| October 24, 2024 | 1.166 |
| October 23, 2024 | 1.172 |
| October 22, 2024 | 1.175 |
| October 21, 2024 | 1.192 |
| October 18, 2024 | 1.224 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.166 |
| October 16, 2024 | 1.185 |
| October 15, 2024 | 1.110 |
| October 14, 2024 | 1.116 |
| October 11, 2024 | 1.104 |
| October 10, 2024 | 1.074 |
| October 09, 2024 | 1.085 |
| October 08, 2024 | 1.098 |
| October 07, 2024 | 1.074 |
| October 04, 2024 | 1.087 |
| October 03, 2024 | 1.051 |
| October 02, 2024 | 0.9844 |
| October 01, 2024 | 0.9512 |
| September 30, 2024 | 1.013 |
| September 27, 2024 | 0.8591 |
| September 26, 2024 | 0.8183 |
| September 25, 2024 | 0.8158 |
| September 24, 2024 | 0.8591 |
| September 23, 2024 | 0.8517 |
| September 20, 2024 | 0.9272 |
| September 19, 2024 | 0.9285 |
| September 18, 2024 | 0.8653 |
| September 17, 2024 | 0.9037 |
| September 16, 2024 | 0.8926 |
| September 13, 2024 | 0.895 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2585
Minimum
Dec 27 2022
7.297
Maximum
Feb 18 2020
1.728
Average
0.9007
Median
Price to Book Value Benchmarks
| EyePoint Pharmaceuticals Inc | 2.605 |
| Cassava Sciences Inc | 9.291 |
| Regenxbio Inc | 1.509 |
| Editas Medicine Inc | 1.114 |
| Apellis Pharmaceuticals Inc | 14.56 |
Price to Book Value Related Metrics
| Price | 5.75 |
| Earnings Yield | -104.5% |
| Market Cap | 119.61M |